LogicBio Therapeutics (LOGC) Misses Q2 EPS by 23c

August 7, 2025 5:03 PM

LogicBio Therapeutics (NASDAQ: LOGC) reported Q2 EPS of ($0.23).

For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.